WoundCon Fall 2021
15 CME Credits | 15 Contact Hours
This CE / CME Activity includes 15 wound care focused presentations facilitated by leading wound educators and originally presented live, November 12, 2021. The activity includes over 14 hours of wound care content.
Earn up to 15 CE/CME credits.
The activity provides up-to-date education on evidence-based wound care practices directly related to issues being experienced in facilities around the globe.
SKIN TEARS: AN UPDATE ON THE EVIDENCE
Skin tears are among the most prevalent acute wounds in all health care settings. At-risk patients should be identified early and preventive measures implemented. This will reduce morbidity and the impact on health care costs.
ADVANCED INTERVENTIONS: ALLOGRAFTS AND VENOUS LEG ULCERS
Chronic venous leg ulcers (VLUs) are caused by an incompetent and poorly functioning venous system. These types of wounds are painful and affect patients’ quality of life. Standards of care usually involve an array of advanced wound care dressings (alginates, foams, etc.) and compression bandaging that must be changed a few times a week, thus driving up costs.
HYPERBARIC OXYGEN THERAPY AND WOUND DRESSINGS: EVALUATING FIRE RISK AND SAFETY STANDARDS
The Undersea and Hyperbaric Medical Society (UHMS) is recognized as the scientific source for HBOT indications, and the Food and Drug Administration has approved HBOT use for various conditions. HBOT is normally a two- to four-week course of sessions in wound care patients who most likely require a wound care dressing. Safety should be a priority to avoid fire risk and accidents.
HOW PHARMACOLOGICAL THERAPIES IMPACT WOUND HEALING
Atypical wounds have rare presentations and typically fail to respond to standard of care practices as a result of complexity. Medications that are prescribed to help with specific chronic conditions may adversely impact healing. Patients with atypical wounds should have a multidisciplinary team working with them closely to decide on a plan of care for best overall outcomes.
WHY WOUND pH MATTERS: THE ACID MANTLE, BIOFILM AND COMPLEX WOUNDS
The normal pH range of skin should be 4.0 to 6.0, but breaks in the skin can lead to a change in pH, which can affect skin healing. An unbalanced pH range can result in delayed wound healing and thus should be recognized and corrected early in the wound management process to encourage best possible outcomes. The role of pH in healing and non-healing wounds needs further investigation, however. Current clinical data show that changes in pH, defective extracellular matrix synthesis and an increase in proteases create a complex wound environment.
SUPPORTING THE POST-OPERATIVE AMPUTEE: IMPROVING OUTCOMES UNDER LIFECHANGING CIRCUMSTANCES
Patients facing amputation need education, emotional support, nutritional support and physical therapy before surgery. The post-operative amputation phase may range from 5 to 14 days, when medical care will be focused on healing and prevention of complications. This is the time when physical and occupational therapies will be initiated.
THE ROLE OF COLLAGEN IN HEALING CHRONIC WOUNDS
In a perfect wound environment, healing phases occur in an organized and timely fashion. Chronic and hard-to-heal wounds, however, do not move correctly through the phases of wound healing and become stalled in the inflammatory phase of healing. Collagen plays a crucial role in every wound healing phase and is the novel triple-helix protein molecule that forms the vital fragment within the extracellular matrix.
HEALING THE HEEL: PRESSURE INJURY PREVENTION, DIAGNOSIS AND TREATMENT
Pressure injuries impact quality of life. Education and prevention are essential in reducing the prevalence of pressure injuries. Tissue destruction in pressure injuries occurs when capillaries supplying the skin structure are compressed for a prolonged time, usually occurring between a bony prominence and a surface.
HOW TO CHOOSE AN ANTIMICROBIAL WOUND DRESSING: QUESTIONS TO ASK AND FACTORS TO CONSIDER
Chronic and hard-to-heal wounds have created a global crisis. Biofilm is present in the majority of chronic and hard-to-heal wounds and delays healing, thus resulting in high financial burdens. It is important for clinicians to have practical knowledge of antimicrobial advanced wound care dressing options, application and plan of care for specific wound types.
“INSIDE-OUT” PRESSURE INJURIES: APPLYING THE ANGIOSOME CONCEPT TO PRESSURE INJURY DEVELOPMENT
Pressure injuries can manifest as intact skin or broken skin normally over a bony prominence where the cause of injury has been prolonged compression leading to capillary occlusion, ischemia and tissue necrosis. The National Pressure Injury Advisory Panel classification and staging system is based on observable tissue damage and depth of tissue destruction but does not represent linear progression. Pathophysiologic mechanisms remain unproven, suggesting that not all pressure injuries are caused by unrelieved pressure.
ANTIMICROBIAL STEWARDSHIP AND WOUND CARE: WHAT’S THE CONNECTION?
Approximately 700,000 people die annually of drug-resistant infections. Experts predict that this figure will increase to 10 million deaths each year by 2050. Antimicrobial stewardship seeks to combat this rising problem, but because infection is a common complication in health care—and especially in wound care—implementation of antimicrobial stewardship programs has been challenging.
WOUND BED PREPARATION BEYOND 2021: IS THERE A ROLE FOR SHOCKWAVE THERAPY?
There are an estimated 30.3 million people with diabetes in America. This population is challenged with chronic conditions and often with chronic wounds that can possibly lead to recurring infections and amputation of the lower limbs.
BEST APPROACHES TO PREVENT RECURRING DIABETIC FOOT ULCERS
Patients with diabetes who develop a diabetic foot ulcer (DFU) usually experience prolonged treatments as a result of the complex nature of the disease state. One complicating factor for patients with diabetes is neuropathy, which can contribute to foot deformity and ulcer development. A multidisciplinary team is necessary to achieve overall wound management while including patients in their care.
VENOUS DISEASES AND THEIR ROLE IN SKIN CHANGES AND ULCERATION
Venous leg ulcers (VLUs) account for 70% to 80% of lower extremity wounds. These wounds often have a mixed etiology of arterial and venous insufficiency. Pathophysiological factors include reflux and obstruction, or a combination of both.
FISTULA FOCUS: PRACTICAL NPWT APPLICATION TIPS FOR MANAGING FISTULAS
A fistula is a connection between two organs that are not normally connected, such as the stomach and the skin. Fistulas develop in various conditions and for a multitude of reasons, such as malignancy, Crohn’s disease and colitis, among others. Many times, fistulas occur after a surgical procedure.
TARGET AUDIENCE
This activity has been designed for practitioners who care for a significant percentage of their patients with chronic and/or acute wounds including but not limited to venous ulcers, pressure ulcers/injuries, diabetic foot ulcers, post-operative wounds, etc., across the health care continuum. This activity is designed to address the educational needs of intermediate and advanced learners.
LEARNING OBJECTIVES
At the end of this activity, participants should be able to:
- Identify current evidence-based concepts in wound management
- Apply essential elements of wound management in a variety of patient settings
- Explore the evidence-base behind wound management interventions
ACTIVITY GOAL
This activity is designed to address the following core and team competencies: patient care, medical knowledge, practice-based learning, evidence-based practice, insurance/reimbursement issues, quality improvement, and interprofessional collaboration.
WoundCon Fall 2021 On-Demand Accreditation
In support of improving patient care, North American Center for Continuing Medical Education (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
PHYSICIANS
NACCME designates this internet enduring activity for a maximum of 15.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PHYSICIAN ASSISTANTS
NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This internet enduring activity is designated for 15 AAPA Category 1 credits. PAs should only claim credit commensurate with the extent of their participation.
NURSING
This continuing nursing education activity awards a maximum of 15 contact hours for this internet enduring activity. Provider approved by the California Board of Registered Nursing, Provider Number 13255 for 15 contact hours. This activity will also award pharmacotherapeutic contact hours, however, final designated credit hours will not be announced until all content is reviewed and approved.
NURSE PRACTITIONER
American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
PODIATRISTS
This activity has been planned and implemented in accordance with the standards and requirements for approval of providers of continuing education in podiatric medicine by North American Center for Continuing Medical Education, LLC (NACCME). NACCME is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. NACCME has approved this internet enduring activity for a maximum of 15 continuing education contact hours.
DIETITIANS
Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit = One CPEU). If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (One 60 minute hour = 1 CPEU). RD’s and DTRs are to select activity type 102 in their Activity Log. Performance Indicator selection is at the learner’s discretion.
Planning Committee
The planning committee comprises: Cathy Milne, APRN, MSN, ANP/ACNS-BC, CWOCN-AP; Jayesh Shah, MD, MHA and Miranda Henry from HMP Communications and Samantha Conforti, Emmie McCalley, and Greaton Sellers from NACCME.
Independent Clinical Reviewers
The independent clinical reviewers for this activity are:
Cathy Milne, APRN, MSN, ANP/ACNS-BC, CWOCN-AP
Connecticut Clinical Nursing Associates
Bristol, Connecticut
Jayesh Shah, MD, MHA
President, South Texas Wound Associates, PA;
Assistant Professor, Dept. of Family Medicine, UT Health
Associate Professor, University of the Incarnate Word Osteopathic School, San Antonio, Texas
Nurse Planner
The nurse planner for this activity is:
Susie Seaman, NP, MSN, CWOCN
Nurse Practitioner
Susie Seaman Wound Care Consulting
San Diego, California
Privacy Policy
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information
as is required for reporting purposes to the appropriate accrediting agency.
NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2021 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert
for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
Grievance Policy
Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by NACCME, LLC may contact Samantha Conforti, Manager, Accreditation and Compliance, by phone at 609-371-1137, by email at sconforti@naccme.com or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. The Manager, Accreditation and Compliance will review the grievance and respond within 30 days of receiving the complaint. If the participant is unsatisfied with the response, an appeal to the Associate Director, Greaton Sellers, Accreditation and Compliance, can be requested for a second level of review. Mr. Sellers can be contacted via phone at 609-371-1137, by email at gsellers@naccme.com or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520.
ADA Statement
North American Center for Continuing Medical Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call (609) 371-1137.
CME/CE Accreditor
North American Center for Continuing
Medical Education, LLC
An HMP Company
104 Windsor Center Drive, Suite 200
East Windsor, NJ 08520
Phone: 609.371.1137
Fax: 609.371.2733
www.naccme.com
Marketing and Management Company
HMP | Healthcare Made Practical
70 East Swedesford Road, Suite 100
Malvern, PA 19355
Toll-Free: 800.237.7285
Phone: 610.560.0500
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
NACCME, LLC is an independent provider of continuing medical education. NACCME, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.
In accordance with our disclosure policies, NACCME is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real conflicts of interest between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME.
Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:
- Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company; and
- Any investigational, off-label, or non-FDA approved content or discussion.
NACCME has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.
Education has been independently peer-reviewed to validate content, mitigate identified conflicts of interest, and ensure:
- All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
- All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
- Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.
FACULTY
The Following speakers have indicated no relevant financial relationships to disclose:
- David G. Armstrong, DPM, MD, PhD
- Dimitri Beeckman, RN, PhD, FEANS
- Caroline E. Fife, MD
- John S. Hogg, MD, DBAR, DABVLM, RPVI, RPhS, RVT, RVS
- Diane Langemo, PhD, RN, FAAN
- Jeff Mize, RRT, CHT, UHMSADS
- Paulinder Rai, DP, MPH
- Jayesh Shah, MD, MHA
- Laura Swoboda, DNP, APRN, FNP-C, CWOCN-AP
The following speakers have indicated relevant financial relationships to disclose:
- Janice M. Beitz, PhD, RN, CS, CNOR, CWOCN-AP, CRNP, MAPWCA, ANEF, FNAP, FAAN – Ostomy Advisory Board: ConvaTec
- Gregory A. Bohn, MD, ABPM/UHM, MAPWCA – Consultant: AROA Biosurgery
- Luis Fernández, MD, KHS, KCOEG, FACS, FASAS, FCCP, FCCM, FICS – Speaker/Advisor: 3M-KCI, Urgo Medical North America, Pacira Medical
- Jennifer Hurlow, GNP-BC, CWCN – Consultant and Speaker: ConvaTec
- George J. Koullias, MD, PhD – Stock owner: Organogenesis
- Mary Anne R. Obst, BSN, RN CCRN, CWON – Speaker’s Bureau: 3M Medical
No other faculty, planner, or staff has disclosed a relevant financial relationship with an ineligible company (commercial interest).
NACCME requires faculty to inform participants whenever off -label/unapproved uses of drugs and/or devices are discussed in their presentations.
Speaker disclosures, as well as off -label/unapproved uses of drugs and/or devices, will be disclosed prior to the start of each session.
In order to receive CME/CE credits, participants must complete the evaluation questions for each session module they wish to claim credit for. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Certificates will be distributed online once the participants submit their request according to the instructions provided in the activity.
Online certificates will be issued by NACCME, the accreditation provider for this activity.
For information about the accreditation of this activity, please contact woundsourceacademy@kestrelhealthinfo.com.